PharmaCyte Biotech, Inc.
Company Information
Industry
Biological Products, (No Diagnostic Substances)
SIC Code
2836
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting company
State of Incorporation
NV
Business Address
3960 HOWARD HUGHES PARKWAY, LAS VEGAS, NV, 89169
Mailing Address
3960 HOWARD HUGHES PARKWAY, LAS VEGAS, NV, 89169
Phone
(917) 595.2850
Fiscal Year End
0430
EIN
621772151
Financial Overview
FY2025 FY
-
Revenue
$30.66M
Net Income
$59.90M
Total Assets
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 4 Insider stock transaction report | April 2, 2026 | View on SEC |
| 4 Insider stock transaction report | April 2, 2026 | View on SEC |
| 8-K Current report of material events | April 2, 2026 | View on SEC |
| 4 Insider stock transaction report | April 2, 2026 | View on SEC |
| 4 Insider stock transaction report | April 2, 2026 | View on SEC |
| 4 Insider stock transaction report | March 18, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | March 18, 2026 | View on SEC |
| 10-Q Quarterly financial report | March 17, 2026 | View on SEC |
| DEF 14A Definitive proxy statement | March 9, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 13, 2026 | View on SEC |
Material Events
8-K
Financial Distress
December 5, 2025
High Impact
- PharmaCyte Biotech received an official notice from Nasdaq for failing to meet the minimum $1.00 bid price rule.
- The company's common stock closed below $1.00 per share for 30 consecutive business days, risking potential delisting from Nasdaq.
Insider Trading
BUY
2 insiders
6 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2836)
Kodiak Sciences Inc.
KOD
Biological Products, (No Diagnostic Substances)
BioAtla, Inc.
BCAB
Biological Products, (No Diagnostic Substances)
Cardiff Oncology, Inc.
CRDF
Biological Products, (No Diagnostic Substances)
HALOZYME THERAPEUTICS, INC.
HALO
Biological Products, (No Diagnostic Substances)
Adaptive Biotechnologies Corp
ADPT
Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.